Updated:
Vanterra Ventures
Vanterra Ventures is a venture and growth equity fund investing in the Future of Consumer Health. We partner with visionary founders building disruptive...
Vanterra Ventures
Vanterra Ventures is a venture and growth equity fund investing in the Future of Consumer Health. We partner with visionary founders building disruptive companies across branded products, digital health, and enabling technologies.
General information
Firm type
Venture Capital
Year founded
2008
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Shad Azimi
Founder & Managing Partner
Sector focus
Frequently asked questions
How does Vanterra Ventures structure its funds?
Vanterra raises closed-end venture capital funds with discrete vintages, supplemented by co-investment vehicles for larger follow-on rounds. The firm has filed fund formation documents with the SEC across multiple cycles, though it does not publicly announce final closes. Its structure follows a standard venture capital model, with management fees and carried interest, but the LP base skews heavily toward family offices rather than traditional institutional allocators.
Who makes investment decisions at Vanterra?
Founder and Managing Partner Shad Azimi leads the investment committee and serves as the primary decision-maker on new commitments. Azimi's background at Goldman Sachs Special Situations Group shapes the firm's diligence approach, which combines growth-equity analytical rigor with early-stage founder assessment. The team remains lean, meaning investment decisions are concentrated at the partner level rather than distributed across junior associates.
Does Vanterra co-invest with other venture firms?
Vanterra regularly co-invests alongside other early-stage managers, particularly in Seed and Series A rounds where syndicate formation is common. The firm's family-office LP network can also provide follow-on capital, meaning Vanterra-backed companies may receive additional investment from the firm's limited partners directly — a structure that blurs the line between fund investment and LP co-investment.
What sectors does Vanterra explicitly avoid?
Vanterra has not publicly stated specific sector exclusions, but its portfolio concentration in enterprise software, fintech, and digital health suggests the firm does not actively pursue hardware-intensive deep tech, biopharma, or consumer social platforms. The firm's operator-heavy LP base also favors B2B business models with clear enterprise sales motion over consumer-facing companies with advertising-dependent revenue models.
How does Vanterra help portfolio companies expand internationally?
Vanterra's limited partner base includes family offices and strategic investors with operating businesses in Europe, the Middle East, and Asia. When portfolio companies seek market entry in those regions, Vanterra facilitates introductions to LPs who can serve as distribution partners, local joint-venture counterparties, or first customers — effectively productizing the LP relationship as a business development resource.
Is Vanterra raising a new fund currently?
Vanterra does not publicly disclose active fundraising and does not issue press releases for fund closes. Public SEC filings provide the primary window into its fundraising cadence, and the firm has historically maintained a discipline of raising successor funds rather than expanding into adjacent strategies or permanent capital vehicles.
Where does Vanterra's LP capital come from?
Vanterra intentionally constructs its LP base from global family offices, strategic corporate investors, and sovereign-affiliated entities — particularly family conglomerates and holding companies in the Gulf Cooperation Council region and Europe. This contrasts with the endowment-and-pension-dominated LP rosters of many US venture firms, and it directly shapes the firm's value proposition around international market access for portfolio companies.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: